Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WISP (Women Choosing Surgical Prevention)

NCT02760849 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02760849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02760849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WISP (Women Choosing Surgical Prevention)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 2, 2016
Completion date
May 31, 2041
Enrollment
374 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

deleterious bard1 gene mutation, deleterious brca1 gene mutation, deleterious brca2 gene mutation, deleterious brip1 gene mutation, deleterious epcam gene mutation, deleterious mlh1 gene mutation, deleterious msh2 gene mutation, deleterious msh6 gene mutation, deleterious palb2 gene mutation, deleterious pms2 gene mutation, deleterious rad51c gene mutation, deleterious rad51d gene mutation, hereditary breast and ovarian cancer syndrome, premenopausal